Clinical Trials List
2009-01-20 - 2010-12-31
Phase III
Terminated9
ICD-10I20.0
Unstable angina
ICD-9411.1
Intermediate coronary syndrome
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 羅志賢 Division of Cardiovascular Diseases
- 蔡瑞鵬 Division of Cardiovascular Diseases
- 蔡政廷 Division of Cardiovascular Diseases
- 劉俊傑 Division of Cardiovascular Diseases
- 彭明正 Division of Cardiovascular Diseases
- Ping-Ing Lee Division of Cardiovascular Diseases
- 顏志軒 Division of Cardiovascular Diseases
- 陳正熙 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- WEI-TIEN CHANG Division of Emergency Medicine
- Hsien Li Kao Division of Cardiovascular Diseases
- MAO-HSIN LIN Division of Cardiovascular Diseases
- 許志能 Division of Cardiovascular Diseases
- - - Division of Cardiovascular Diseases
- YEN-HUNG LIN Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 黃玄禮 Division of Cardiovascular Diseases
- 鄭詩璁 Division of Cardiovascular Diseases
- 林正豐 Division of Cardiovascular Diseases
- 周星輝 Division of Cardiovascular Diseases
- 張恆嘉 Division of Cardiovascular Diseases
- 留至仁 Division of Cardiovascular Diseases
- 葉冠宏 Division of Cardiovascular Diseases
- 廖朝崧 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 顏志軒 Division of Cardiovascular Diseases
- 蔡瑞鵬 Division of Cardiovascular Diseases
- 羅志賢 Division of Cardiovascular Diseases
- 劉俊傑 Division of Cardiovascular Diseases
- 蔡政廷 Division of Cardiovascular Diseases
- 彭明正 Division of Cardiovascular Diseases
- Ping-Ing Lee Division of Cardiovascular Diseases
- 陳正熙 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
105 participants
-
Global
715 participants
